We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+7.38%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
AUM
$201M
AUM Growth
+$13.3M
Cap. Flow
+$2.55M
Cap. Flow %
1.27%
Top 10 Hldgs %
19.35%
Holding
712
New
41
Increased
229
Reduced
120
Closed
19

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$329K
2
UNP icon
Union Pacific
UNP
+$202K
3
ABT icon
Abbott
ABT
+$194K
4
R icon
Ryder
R
+$164K
5
CVX icon
Chevron
CVX
+$158K

Sector Composition

Rank Sector Weight
1 Technology 25.43%
2 Real Estate 18.25%
3 Industrials 12.28%
4 Healthcare 8.95%
5 Consumer Discretionary 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AA icon
626
Alcoa
AA
$13.2B
$1.12K ﹤0.01%
33
LITE icon
627
Lumentum
LITE
$69.3B
$1.08K ﹤0.01%
19
ACET icon
628
Adicet Bio
ACET
$74.7M
$1.07K ﹤0.01%
27
RIG icon
629
Transocean
RIG
$5.82B
$1.05K ﹤0.01%
150
THER
630
DELISTED
THERATECHNOLOGIES INC COM
THER
$1K ﹤0.01%
1,193
JEMA icon
631
JPMorgan ActiveBuilders Emerging Markets Equity ETF
JEMA
$1.66B
$897 ﹤0.01%
25
BHC icon
632
Bausch Health
BHC
$2.34B
$872 ﹤0.01%
109
SFIX
633
Stitch Fix
SFIX
$560M
$866 ﹤0.01%
225
JPIE icon
634
JPMorgan Income ETF
JPIE
$10.3B
$859 ﹤0.01%
19
VOO icon
635
Vanguard S&P 500 ETF
VOO
$1.03T
$815 ﹤0.01%
2
VIG icon
636
Vanguard Dividend Appreciation ETF
VIG
$114B
$812 ﹤0.01%
5
OMER icon
637
Omeros
OMER
$959M
$794 ﹤0.01%
146
COIN icon
638
Coinbase
COIN
$40.5B
$787 ﹤0.01%
11
RAIN
639
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$787 ﹤0.01%
656
CRSP icon
640
CRISPR Therapeutics
CRSP
$5.17B
$786 ﹤0.01%
14
NGNE icon
641
Neurogene
NGNE
$712M
$768 ﹤0.01%
46
SENS icon
642
Senseonics Holdings Inc
SENS
$366M
$763 ﹤0.01%
50
QMCO icon
643
Quantum Corp
QMCO
$474M
$742 ﹤0.01%
34
FSLY icon
644
Fastly Inc
FSLY
$3.66B
$741 ﹤0.01%
47
ARNC
645
DELISTED
Arconic Corporation
ARNC
$740 ﹤0.01%
25
VYMI icon
646
Vanguard International High Dividend Yield ETF
VYMI
$21.3B
$728 ﹤0.01%
12
AKBA icon
647
Akebia Therapeutics
AKBA
$252M
$692 ﹤0.01%
756
SLB icon
648
SLB Ltd
SLB
$75B
$688 ﹤0.01%
14
DHC
649
Diversified Healthcare Trust
DHC
$2.14B
$675 ﹤0.01%
300
AOUT icon
650
American Outdoor Brands
AOUT
$157M
$668 ﹤0.01%
77

Similar funds

Truvestments Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Truvestments Capital held 712 positions worth $201M, up 7.1% from $188M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Truvestments Capital's Q2 2023 filing shows 41 new, 229 increased, 120 reduced and 19 closed positions. Its largest new stake was Ready Capital: 11,266 shares worth $127K. The largest sale was Triton International Limited, an estimated $3.64M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Real Estate and Industrials.

  • Truvestments Capital's largest Q2 2023 buy was Ready Capital: 11,266 shares worth $127K.
  • Truvestments Capital added most to Merck in Q2 2023, an estimated $329K increase.
  • Truvestments Capital's biggest Q2 2023 reduction was Triton International Limited, cutting an estimated $3.64M.
  • Truvestments Capital fully exited BorgWarner in Q2 2023, selling an estimated $300K.
  • Truvestments Capital's ten largest holdings make up 19% of its $201M portfolio in Q2 2023.
  • Truvestments Capital opened 41 new positions and closed 19 in Q2 2023.
  • Truvestments Capital's portfolio value rose 7.1% quarter-over-quarter to $201M.

Based on Truvestments Capital's 13F filing for Q2 2023, filed 10 Aug 2023.